Document:ICH ICH Guidelines -: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Migrate to Template:DocumentData for PageForms (GxPlexBot) |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{DocumentData | |||
|reference=ICH ICH Guidelines - | |reference=ICH ICH Guidelines - | ||
|validity_area=ICH | |validity_area=ICH | ||
Latest revision as of 12:54, 16 July 2026
| Document information | |
|---|---|
| Reference | ICH ICH Guidelines - |
| Validity area | ICH |
| Scope(s) | HM |
| Document name | ICH Guidelines |
| Version / Revision | - |
| Status | N.A. |
| Document type | Corpus of texts |
| Language(s) | EN |
| Description | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
- Q: Quality guidelines (conduct of stability studies, defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP) risk management, …) - S: Safety Guidelines (uncover potential risks like carcinogenicity, genotoxicity and reprotoxicity, non-clinical testing strategy for assessing the QT interval prolongation liability, …) - E: Efficacy Guidelines (design, conduct, safety and reporting of clinical trials) - M: Multidisciplinary Guidelines (cross-cutting topics which do not fit uniquely into one of the Quality, Safety and Efficacy categories. It includes the ICH medical terminology [MedDRA], the Common Technical Document [CTD] and the development of Electronic Standards for the Transfer of Regulatory Information [ESTRI]) |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
No references yet.
